Hironobu Goto, Taro Oshikiri, Takashi Kato, Yoshiaki Nagatani, Yohei Funakoshi, Yasufumi Koterazawa, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, et al. Protocol for a phase II study to evaluate the efficacy and safety of nivolumab as a postoperative adjuvant therapy for patients with esophageal cancer treated with preoperative docetaxel, cisplatin plus 5-fluorouracil treatment (PENTAGON trial). PLOS ONE. 2024. 19. 4. e0299742-e0299742
Yasufumi Koterazawa, Taro Oshikiri, Hironobu Goto, Takashi Kato, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, et al. ASO Visual Abstract: Impact of Tumor Size on Survival Outcome in Esophageal Squamous Cell Carcinoma After Esophagectomy Following Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 2024. 31. 6. 4018-4018
YUKI AZUMI, SHINGO KANAJI, RYUICHIRO SAWADA, HITOSHI HARADA, NAOKI URAKAWA, HIRONOBU GOTO, HIROSHI HASEGAWA, KIMIHIRO YAMASHITA, TAKERU MATSUDA, TARO OSHIKIRI, et al. Significance of Preoperative Tooth Loss in Patients Who Underwent Gastrectomy for Gastric Cancer. Cancer Diagnosis & Prognosis. 2024. 4. 1. 51-56
TAKASHI NAKANISHI, TAKERU MATSUDA, KIMIHIRO YAMASHITA, HIROSHI HASEGAWA, RYUICHIRO SAWADA, HITOSHI HARADA, NAOKI URAKAWA, HIRONOBU GOTO, SHINGO KANAJI, TARO OSHIKIRI, et al. Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy. Anticancer Research. 2023. 44. 1. 229-237
Yasufumi Koterazawa, Taro Oshikiri, Hironobu Goto, Takashi Kato, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, et al. Impact of Tumor Size on Survival Outcome in Esophageal Squamous Cell Carcinoma After Esophagectomy Following Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 2023. 31. 4. 2482-2489